CHS
CHS Inc.
Key figures
Period Sep 2024 to Aug 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$35.5B
Operating marginCalculated
0.3%
Net assets to total assetsCalculated
58.7%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
0.3%
Growth (revenue, 4-year average)
★☆☆☆☆position among all companies
-2.0%
Capital efficiency
★★☆☆☆position among all companies
5.4%
Revenue and profit
Performance, financial position and capital allocation
CHS
Recent performance trends
CHS
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$38.4 billion | US$47.8 billion | US$45.6 billion | US$39.3 billion | US$35.5 billion |
| Operating income | US$0.2 billion | US$1.1 billion | US$1.3 billion | US$0.6 billion | US$90.75 million |
| Net income | US$0.6 billion | US$1.7 billion | US$1.9 billion | US$1.1 billion | US$0.6 billion |
| Total assets | US$17.6 billion | US$18.8 billion | US$19.0 billion | US$18.7 billion | US$18.9 billion |
| Shareholders' equity | US$9.0 billion | US$9.5 billion | US$10.4 billion | US$10.8 billion | US$11.1 billion |
| Net cash provided by (used in) operating activities | US$0.8 billion | US$1.9 billion | US$3.3 billion | US$1.3 billion | US$0.6 billion |
| Net cash provided by (used in) investing activities | US$-0.1 billion | US$-0.5 billion | US$-1.0 billion | US$-1.4 billion | US$-0.9 billion |
| Net cash provided by (used in) financing activities | US$-0.3 billion | US$-1.1 billion | US$-1.4 billion | US$-0.8 billion | US$-0.2 billion |
| Cash and cash equivalents | US$0.4 billion | US$0.8 billion | US$1.8 billion | US$0.8 billion | US$0.3 billion |
Revenue scale in the same industry
CHS
Wholesale (nondurable goods): 16 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 McKESSONFY Mar 2026 US$403.4B
- 2 CencoraFY Sep 2025 US$321.3B
- 3 Cardinal HealthFY Jun 2026 US$254.2B
- … 2 companies
- 6 US Foods HoldingFY Dec 2025 US$39.4B
- 7 World KinectFY Dec 2025 US$36.9B
- 8 CHSThis companyFY Aug 2025 US$35.5B
- 9 United Natural FoodsFY Aug 2026 US$31.2B
- 10 Global Partners LPFY Dec 2025 US$18.6B
- … 6 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.7 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.9 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.6 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.7 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$11.1 billion | Consolidated | Disclosed |
| Non-controlling interests | US$3.48 million | Consolidated | Disclosed |
| Net assets | US$11.1 billion | Consolidated | Disclosed |
| Net sales | US$35.5 billion | Consolidated | Disclosed |
| Operating income | US$90.75 million | Consolidated | Disclosed |
| Net income | US$0.6 billion | Consolidated | Disclosed |
| Total assets | US$18.9 billion | Consolidated | Disclosed |
| Operating margin | 0.3% | Consolidated | Calculated |
| Net assets to total assets | 58.7% | Consolidated | Calculated |
| Net margin | 1.7% | Consolidated | Calculated |
| Return on equity | 5.4% | Consolidated | Calculated |